Walnut Shell Glasses Moxibustion for Dry Eye Syndrome

Last updated: July 6, 2018
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dry Eyes

Sjogren's Syndrome

Dry Eye Disease

Treatment

N/A

Clinical Study ID

NCT03116776
2016-121-KY-01
  • Ages 18-75
  • All Genders

Study Summary

This trial is designed to evaluate the efficacy of walnut shell glasses moxibustion for dry eye syndrome compared with sodium hyaluronate eye drops.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. eyes are in line with dry eye diagnostic criteria.

  2. Age 18 to 75 years,

  3. signed informed consent, voluntary adherence to treatment for more than 1 month.

Exclusion

Exclusion Criteria:

  1. combined with other eye disease (such as conjunctiva, cornea and iris have significantlesions).

  2. eye surgery within 3 months.

  3. pregnant or lactating women.

  4. oral the drugs which could inhibit lacrimal gland secretion.

  5. severe meibomian gland dysfunction.

  6. severe eye burns, chemical injury patients.

  7. combined with cardiovascular and cerebrovascular, liver, kidney and hematopoieticsystem and other serious primary disease, mental patients.

  8. patients with Sjogren's syndrome.

  9. patients who are participating in other drug clinical trials.

  10. patients who are using other drugs or therapies for the treatment of dry eyes.

Study Design

Total Participants: 128
Study Start date:
May 01, 2017
Estimated Completion Date:
December 30, 2018

Connect with a study center

  • Guang'anmen Hospital, China Academy of Chinese Medical Sceince

    Beijing, Beijing 100053
    China

    Active - Recruiting

  • Guang'anmen Hospital, China Academy of Chinese Medical Science

    Beijing, Beijing 100053
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.